Table 3

Sensitivity of methylation analysis in urine samples of patients with bladder cancer

GeneSensitivity* No. (%)
BCL2 24/37 (64.9)
TERT 19/37 (51.4)
DAPK 8/37 (21.6)
Specificity29/37 (78.4)
  • * Sensitivity was defined as the percentage of methylated samples among urine samples from tumor patients (n = 37).